Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab

OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in the treatment of retinal vasoproliferative disorders in adults and, more recently, in infants with retinopathy of prematurity. Recently, it has been proposed that vascular endothelial growth factor acts...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusco, Maria Alice, Portes, André Luís Freire, Allodi, Silvana, de Moraes Junior, Haroldo Vieira, Monteiro, Mário Luiz Ribeiro, de Oliveira Miguel, Nádia Campos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248603/
https://www.ncbi.nlm.nih.gov/pubmed/22249482
http://dx.doi.org/10.6061/clinics/2012(01)10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248603/
https://www.ncbi.nlm.nih.gov/pubmed/22249482
http://dx.doi.org/10.6061/clinics/2012(01)10

Ejemplares similares